Moxon (Moxonidine)

Moxonidine is used to treat hypertension by modulating central sympathetic activity.

• Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension.
• Mild to moderate hypertension: provides effective blood pressure control when monotherapy is required.
• Hypertension in patients intolerant to other agents: offers an alternative mechanism for blood pressure reduction.

• Moxonidine acts as a selective central imidazoline I1 receptor agonist. By stimulating these receptors in the medullary vasomotor centre, it diminishes sympathetic nervous system activity, which leads to reduced peripheral vascular resistance and a consequent fall in arterial blood pressure.

Moxonidine may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects

• Dry mouth: sensation of oral dryness without obvious cause.
• Fatigue: persistent feeling of tiredness or lack of energy.
• Dizziness: light‑headedness, especially when standing quickly.
• Headache: mild to moderate cranial pain.
• Nausea: feeling of queasiness or urge to vomit.
• Insomnia: difficulty initiating or maintaining sleep.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure causing faintness.
• Bradycardia: unusually slow heart rate.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Cardiac arrhythmia: irregular heart rhythm.
• Syncope: sudden loss of consciousness.

Before initiating therapy with Moxonidine, certain precautions should be observed.

• Monitor blood pressure: ensure adequate control and avoid excessive drops.
• Assess renal function: adjust use in patients with impaired kidney function.
• Evaluate hepatic function: consider liver status before prescribing.
• Avoid abrupt discontinuation: taper dose to prevent rebound hypertension.
• Use caution in cardiovascular disease: patients with heart failure or ischemic disease need close observation.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Moxonidine can interact with other medicines, requiring attention to avoid adverse outcomes. Major Interactions (Avoid):\n- Concomitant central antihypertensives (e.g., clonidine): may cause additive hypotensive effect.

• Other imidazoline agonists: risk of excessive blood pressure reduction.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may enhance bradycardia and hypotension.
• Diuretics: can amplify volume depletion and low blood pressure.
• ACE inhibitors or ARBs: may increase risk of renal impairment.
• NSAIDs: may attenuate antihypertensive efficacy.
• Alcohol: can potentiate sedative and hypotensive effects.